Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TNK for Loculated Pleural Effusions in Malignancy
NCT01580618Phase 3Terminated
- Sponsor
- Kaiser Permanente
- Start
- Jan 2008
- Primary completion
- Sep 2011
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in pleural effusion, sponsored by Kaiser Permanente. Started Jan 2008; status: terminated.
02
Drugs
tenecteplase
03
Conditions
pleural effusion
Beyond the preview
Go deeper on NCT01580618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01580618.